Short Conceptual Overview
Orexin modulates brown adipose tissue thermogenesis
Christopher J. Madden *, Domenico Tupone and Shaun F. Morrison
Department of Neurological Surgery , Oregon Health and Science University, Portland, OR 97239 , USA
* Corresponding author e-mail: [email protected]
Abstract
Non-shivering thermogenesis in brown adipose tissue (BAT) plays an important role in thermoregulation. In addition, activations of BAT have important implications for energy homeostasis due to the metabolic consumption of energy reserves entailed in the production of heat in this tissue. In this conceptual overview, we describe the role of orexins/hypocre- tins within the central nervous system in the modulation of thermogenesis in BAT under several physiological conditions.
Within this framework, we consider potential neural mecha- nisms underlying the pathological conditions associated with the absence of the central orexinergic modulation of BAT ther- mogenesis and energy expenditure. Overall, the experimental basis for our understanding of the role of central orexin in reg- ulating body temperature and energy homeostasis provides an illustrative example that highlights several general principles and caveats that should help guide future investigations of the neurochemical regulation of thermogenesis and metabolism.
Keywords: cannabinoid; narcolepsy; obesity; stress;
ultradian rhythm.
Introduction
The regulation of body temperature by the central nervous system is critical for mammalian survival in a wide variety of thermal environments. Small variations in core body tem- perature within the physiological range often occur during behavior and may be functionally relevant. However, large deviations in cellular temperature can suffi ciently alter a vari- ety of molecular properties, including enzymatic activities, diffusion capacity, and membrane fl uidity, to impair cellular function. Severe disruptions in cellular function result in loss of motor coordination, mental confusion, loss of conscious- ness, signifi cant respiratory and cardiovascular dysfunction, and eventual death.
Signifi cant progress has been made in our understanding of the fundamental central nervous system circuitry that reg- ulates body temperature [see refs. (1 – 4) ]. Not surprisingly,
the excitatory amino acid glutamate and the inhibitory amino acid GABA are the primary neurotransmitters within the fundamental central neural pathways for thermoregulation.
In addition, body temperature can be infl uenced by an exten- sive array of peptides and other central neurotransmitters, including (but not limited to) hypocretin/orexin, galanin, melanin-concentrating hormone, neuropeptide Y, oxyto- cin, glucagon-like peptide 1, cholecystokinin, cocaine- and amphetamine-related transcript, melanocortins, opioids, thyrotropin-releasing hormone, corticotropin-releasing fac- tor, tuberoinfundibular peptide of 39-amino-acid residues (TIP-39), dopamine, norepinephrine, epinephrine, serotonin, histamine, insulin, and leptin. However, the precise neuroana- tomical sites of action and the specifi c mechanisms by which many of these neurochemicals infl uence the fundamental neurocircuitry for thermoregulation remain unknown. In this article, we will use an illustrative example the infl uence of orexin on thermoregulation, to highlight some of the gen- eral principles and caveats that should guide experiments to understand the precise mechanisms by which neurochemicals may interact to infl uence thermoeffector activation.
Orexin neurons contribute to the regulation of BAT thermogenesis
Orexins/hypocretins (5, 6) are peptides synthesized primar- ily by neurons located in the lateral, perifornical, and dorso- medial areas of the hypothalamus. These orexinergic neurons have widespread projections in the brain that include many thermoregulatory areas, such as the preoptic area, dorso- medial hypothalamus, parapyramidal area (PaPy), and the rostral raphe pallidus (rRPa) (7 – 9) . The rRPa is especially relevant to thermogenesis as it is the location of the sympa- thetic premotor neurons for BAT (10, 11) . We have recently demonstrated a role of orexin in the rRPa in the control of BAT thermogenesis (9) . Transynaptic retrograde virus tracers injected in BAT as well as injections of the retrograde tracer cholera toxin subunit-b in the rRPa and PaPy highlighted a direct projection from orexinergic neurons to rRPa and PaPy sympathetic premotor neurons controlling BAT thermogene- sis. Furthermore, nanoinjection of orexin in the rRPa or PaPy, or nanoinjection of N -methyl- d -aspartate (NMDA) in the per- ifornical area of the lateral hypothalamus containing orexin- ergic neurons potentiated the ongoing BAT sympathetic nerve acti vity (SNA) elicited by mild cooling of core body tem- perature. However, during a slightly warm condition when the BAT sympathetic nerve was quiescent, neither nanoinjec- tion of orexin in the rRPa nor direct activation of orexinergic
neurons by nanoinjections of NMDA in the perifornical area of the lateral hypothalamus increased BAT SNA (9) . Thus, orexin appears to serve as a modulator that changes the gain of the central thermoregulatory system to facilitate ongoing sympathetic activity to BAT and BAT thermogenesis.
Figure 1 illustrates several potential mechanisms by which orexin-mediated facilitation of the activity of BAT sympathetic premotor neurons could occur within the rRPa. Orexin could act by inhibiting GABA release onto BAT sympathetic premo- tor neurons in the rRPa, consistent with the increases in BAT SNA that can be driven by blockade of GABA A receptors in this region (12) . Interestingly, within the periaqueductal gray, orexin inhibits the release of GABA by cannabinoid-mediated retrograde neurotransmission, in which endocannabinoid, released from the postsynaptic cell in response to orexin recep- tor activation, diffuses retrogradely to inhibit GABA release from local presynaptic terminals (13) . Orexin could also pre- synaptically potentiate glutamate release onto BAT sympa- thetic premotor neurons of the rRPa, similar to mechanisms described for the potentiation of muscle tone with microinjec- tion of orexin in somatic motor nuclei (14) . In addition, orexin could act directly on sympathetic premotor neurons in the rRPa to alter their responsiveness to synaptic inputs. Although there are no data quantifying the phenotypes of the targets of
orexin terminals within the rRPa, orexin fi bers do form close appositions to serotonergic neurons (unpublished observation), consistent with the interesting possibility that the modulatory effects of orexin could be explained by effects on the seroton- ergic, BAT sympathetic premotor neurons in the rRPa. Indeed, similar to the effect of orexin in the rRPa, activation of seroton- ergic receptors in the spinal cord changes the gain of the spinal thermogenic network by potentiating glutamatergic excitation of BAT sympathetic preganglionic neurons (15 – 17) .
Role of orexin in the ultradian cycle of BAT thermogenesis
Ultradian rhythms are those with a periodicity of < 24 h.
Ultradian rhythms in rats have been described for sleep/wake cycles, motor activity, arterial pressure, and heart rate. An ultra- dian rhythm in BAT thermogenesis has also been demonstrated, with increases in BAT temperature occurring every ∼ 1 – 2 h (18, 19) . A role for orexin in the regulation of the ultradian rhythm of BAT thermogenesis has been suggested (18, 20) . Consistent with this hypothesis, injection of orexin into the cerebral ventricles increases BAT SNA and BAT temperature (21) , and the acti vity of orexinergic neurons as well as the lev- els of orexin in the extracellular fl uid of the central nervous system correlate well with the sleep/wake state of the animal, with higher indices of orexin activity during the waking state (22 – 24) . Unfortunately, the presence (or absence) of an ultra- dian rhythm in BAT temperature in orexin-null mice has not yet been described, although these animals do have disrupted ultradian sleep/wake cycles characterized by shorter bouts of wakefulness compared with control mice (19, 25) . We postu- late that the ultradian increases in BAT temperature are medi- ated by the periodic release of orexin in the rRPa and PaPy, resulting in increases in the gain of thermogenic neurotrans- mission that, in turn, increase body and brain temperatures.
What are the functional implications of the ability of orexin to increase the gain of the thermogenic system ? An interest- ing, although untested, hypothesis is that the ultradian rhythm of BAT thermogenesis facilitates neural activity and thereby improves brain function (26) . Similarly, given the close cor- relation of BAT thermogenesis and the resulting increase in body temperature with periods of wakefulness, thermogen- esis in this tissue may act to optimize metabolic function dur- ing periods requiring enhanced performance in general, and, conversely, low levels of thermogenesis during sleep states may act to conserve limited metabolic resources. Likewise, changing the gain of the excitatory neurotransmitter system driving a thermogenic effector, such as BAT, which consumes energy stores to produce heat, would have clear functional consequences for energy homeostasis (see below).
Role of orexin neurons in the stress-induced increase in body temperature
Zhang and colleagues (27) have demonstrated that the increase in core body temperature evoked by repeated handling stress Figure 1 Schematic diagram summarizing several proposed mod-
els of the detailed mechanisms responsible for the modulation of brown adipose tissue (BAT) sympathetic nerve activity and thermo- genesis evoked by the actions of orexin in the raphe pallidus.
Orexin peptide released from an orexinergic terminal (pink terminal) in the raphe pallidus may 1) act at postsynaptic orexin receptors on a sympathetic premotor neuron (gray neuron) for BAT to increase its responsiveness to other excitatory synaptic inputs; 2) act at orexin receptors on glutamatergic terminals (blue terminal) to presynapti- cally potentiate glutamate release onto sympathetic premotor neu- rons for BAT; 3) act on sympathetic premotor neurons for BAT to stimulate the release of endocannabinoids that subsequently serve as retrograde neurotransmitters to inhibit ongoing GABAergic input (yellow terminal) to sympathetic premotor neurons for BAT.
is attenuated in mice that lack orexin neurons compared with wild-type mice. Surprisingly, prepro-orexin knockout mice that do not produce orexin peptides have relatively normal stress-evoked increases in core body temperature (27) . On the basis of these data, it has been suggested that orexin-contain- ing neurons may be involved in stress-evoked increases in body temperature through the release of neurochemicals other than orexin (e.g., dynorphin or glutamate, which are normally co-expressed in orexin neurons) (27) .
Particular caution is warranted when interpreting geneti- cally driven ablation and knockout models as there is always the possibility for developmental changes or compensatory mechanisms, as well as unintended consequences on addi- tional cell populations beyond those specifi cally targeted [e.g., due to developmental expression patterns that differ from those in adult animals; see ref. (28) ]. This may also be true in the case of orexin. Orexin is required for the development and differentiation of BAT, and orexin administration during ges- tation in orexin-null dams rescues this developmental defect in the newborn pups (29) . The placenta may be the source of the orexin required for BAT development (29) . However, how could this defect explain the differences observed between prepro-orexin knockout mice and orexin neuron-ablated mice ? As the source of the functionally important orexin may be the placenta, the genotype of the dam could determine the development of BAT in the offspring. The prepro-orexin knockout mice were generated by breeding heterozygotes (27) ; therefore, the dams will produce orexin as adults (30) . Unfortunately, it is not clear from the methodological descrip- tion of the generation of orexin neuron-ablated mice whether the dams are devoid of orexin (the specifi c genotype of the dams is not stated) (27) . However, if orexin neuron-ablated dams were used, then the differential expression of orexin in the placenta of the dams would be expected to result in dif- ferences in the development of BAT that could contribute to a difference in the stress-evoked increase in body temperature that is independent of alterations in the central nervous sys- tem of the pups. There is also an apparent controversy con- cerning the UCP-1 expression levels in orexin knockout mice [compare, for instance, Figure S1E in ref. (29) to Figure 3 in ref. (27) ]. Obviously, additional insights are necessary to resolve these issues.
Role of orexin in obesity
Narcolepsy is a neurological disorder principally characteri- zed by altered sleep/wake cycles, in most cases attributable to reduced orexin neurotransmission (30 – 32) . In addition to the disturbances in sleep/wake cycles, there is a well-recognized association between narcolepsy and obesity in human patients and animal models of the disease (33 – 38) . The increase in body weight in human patients with orexin defi ciencies occurs despite a reduced caloric intake (39) and a normal total physical activity compared either with healthy control subjects (40) or with patients with idiopathic hypersomnia (34) . Similarly in mice that lack orexin, weight gain occurs despite reduced food intake; however, in mouse models,
a decrease in spontaneous motor activity likely contributes to the weight gain (41) . Impaired thermogenesis in BAT has also been suggested to play a role in the propensity for weight gain in orexin-null mice (29) . There are currently no studies demonstrating a role for diminished activation of BAT in the increased incidence of obesity of narcoleptic patients; how- ever, this hypothesis would be consistent with the recent dem- onstrations of an inverse relation between the activity of BAT and body mass index in adult humans (42 – 45) . Conversely, augmented orexin activity prevents diet-induced obesity and could contribute to a lean phenotype (46) .
Highlights
Orexin has pleiotropic effects on thermogenesis in brown 1.
adipose tissue. These include synergistic contributions to the development and differentiation of brown adipocytes and to the neurally regulated activation of this tissue under various physiological conditions. In addition, orexin neu- rons may contribute to thermogenesis through the release of neurotransmitters other than the orexin peptide.
Neurochemicals may act as modulators, which by them- 2.
selves may be insuffi cient to drive thermoeffector systems, but instead act to change the gain of neural activity driven primarily by other neurotransmitters.
Because neurons express multiple neurotransmitters, neu- 3.
rochemical phenotyping may have limited utility until the unique and the ‘ interactive ’ roles of each neurochemi- cal in target cell regulation have been addressed. This is especially important when using genetic methods to spe- cifi cally alter a ‘ neurochemically specifi c ’ cell population as the important neurotransmitter under a given condition may indeed differ from the genotype used to target the cell.
‘ Knockout ’ models must be interpreted with caution 4.
owing to developmental compensation and/or potential for changes in development.
References
1. Morrison SF, Nakamura K, Madden CJ. Central control of ther- mogenesis in mammals. Exp Physiol 2008; 93: 773 – 97.
2. Morrison SF, Nakamura K. Central neural pathways for thermo- regulation. Front Biosci 2011; 16: 74 – 104.
3. Morrison SF. 2010 Carl Ludwig Distinguished Lectureship of the APS Neural Control and Autonomic Regulation Section: central neural pathways for thermoregulatory cold defense. J Appl Physiol 2011; 110: 1137 – 49.
4. Morrison SF, Madden CJ, Tupone D. Central control of brown adipose tissue thermogenesis. Front Endocrinol 2012; 3: 1 – 19.
5. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG. The hypocretins: hypothalamus-specifi c peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322 – 7.
6. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S,
Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled recep- tors that regulate feeding behavior. Cell 1998; 92: 573 – 85.
7. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18:
9996 – 10015.
8. Berthoud HR, Patterson LM, Sutton GM, Morrison C, Zheng H.
Orexin inputs to caudal raphe neurons involved in thermal, car- diovascular, and gastrointestinal regulation. Histochem Cell Biol 2005; 123: 147 – 56.
9. Tupone D, Madden CJ, Cano G, Morrison SF. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J Neurosci 2011; 31: 15944 – 55.
10. Morrison SF. RVLM and raphe differentially regulate sympa- thetic outfl ows to splanchnic and brown adipose tissue. Am J Physiol 1999; 276: R962 – 73.
11. Nakamura K, Matsumura K, Hubschle T, Nakamura Y, Hioki H, Fujiyama F, Boldogkoi Z, Konig M, Thiel HJ, Gerstberger R, Kobayashi S, Kaneko T. Identifi cation of sympathetic pre- motor neurons in medullary raphe regions mediating fever and other thermoregulatory functions. J Neurosci 2004; 24:
5370 – 80.
12. Morrison SF, Sved AF, Passerin AM. GABA-mediated inhibi- tion of raphe pallidus neurons regulates sympathetic outfl ow to brown adipose tissue. Am J Physiol 1999; 276: R290 – 7.
13. Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. J Neurosci 2011; 31: 14600 – 10.
14. Peever JH, Lai YY, Siegel JM. Excitatory effects of hypo- cretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003; 89:
2591 – 600.
15. Madden CJ, Morrison SF. Serotonin potentiates sympathetic responses evoked by spinal NMDA. J Physiol 2006; 577:
525 – 37.
16. Madden CJ, Morrison SF. Brown adipose tissue sympathetic nerve activity is potentiated by activation of 5-hydroxytrypta- mine (5-HT)1A/5-HT7 receptors in the rat spinal cord.
Neuropharmacology 2008; 54: 487 – 96.
17. Madden CJ, Morrison SF. Endogenous activation of spinal 5-hy- droxytryptamine (5-HT) receptors contributes to the thermoregu- latory activation of brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 2010; 298: R776 – 83.
18. Ootsuka Y, de Menezes RC, Zaretsky DV, Alimoradian A, Hunt J, Stefanidis A, Oldfi eld BJ, Blessing WW. Brown adipose tissue thermogenesis heats brain and body as part of the brain-coordi- nated ultradian basic rest-activity cycle. Neuroscience 2009; 164:
849 – 61.
19. Mochizuki T, Klerman EB, Sakurai T, Scammell TE. Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 2006; 291: R533 – 40.
20. Zhang S, Zeitzer JM, Sakurai T, Nishino S, Mignot E. Sleep/
wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol 2007; 581: 649 – 63.
21. Monda M, Viggiano A, De Luca V. Paradoxical [correction of parodoxical] effect of orexin A: hypophagia induced by hyper- thermia. Brain Res 2003; 961: 220 – 8.
22. Takahashi K, Lin JS, Sakai K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 2008; 153: 860 – 70.
23. Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light- dark cycle and sleep-wake activities. Eur J Neurosci 2001; 14:
1075 – 81.
24. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001; 21:
1656 – 62.
25. Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE. Behavioral state instability in orexin knock-out mice. J Neurosci 2004; 24: 6291 – 300.
26. Blessing W, Mohammed M, Ootsuka Y. Heating and eating:
brown adipose tissue thermogenesis precedes food ingestion as part of the ultradian basic rest-activity cycle in rats. Physiol Behav 2011; 105: 966 – 74.
27. Zhang W, Sunanaga J, Takahashi Y, Mori T, Sakurai T, Kanmura Y, Kuwaki T. Orexin neurons are indispensable for stress-induced thermogenesis in mice. J Physiol 2010; 588: 4117 – 29.
28. Padilla SL, Carmody JS, Zeltser LM. Pomc-expressing progeni- tors give rise to antagonistic neuronal populations in hypotha- lamic feeding circuits. Nat Med 2010; 16: 403 – 5.
29. Sellayah D, Bharaj P, Sikder D. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab 2011; 14: 478 – 90.
30. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M.
Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999 ; 98: 437 – 51.
31. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E.
Hypocretin (orexin) defi ciency in human narcolepsy. Lancet 2000; 355: 39 – 40.
32. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narco- lepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365 – 76.
33. Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obe- sity in narcoleptic patients and relatives. Eur Arch Psychiat Clin Neurosci 2001; 251: 85 – 9.
34. Kok SW, Overeem S, Visscher TL, Lammers GJ, Seidell JC, Pijl H, Meinders AE. Hypocretin defi ciency in narcoleptic humans is associated with abdominal obesity. Obes Res 2003; 11:
1147 – 54.
35. Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E. Low cerebrospinal fl uid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001; 50:
381 – 8.
36. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 2000; 355:
1274 – 5.
37. Schuld A, Beitinger PA, Dalal M, Geller F, Wetter TC, Albert ED, Hebebrand J, Pollmacher T. Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers. Sleep Med 2002; 3: 335 – 9.
38. Poli F, Plazzi G, Di Dalmazi G, Ribichini D, Vicennati V, Pizza F, Mignot E, Montagna P, Pasquali R, Pagotto U. Body mass index- independent metabolic alterations in narcolepsy with cataplexy.
Sleep 2009; 32: 1491 – 7.
39. Lammers GJ, Pijl H, Lestra J, Langius JA, Buunk G, Meinders AE. Spontaneous food choice in narcolepsy. Sleep 1996; 19:
75 – 6.
40. Middelkoop HA, Lammers GJ, Van Hilten BJ, Ruwhof C, Pijl H, Kamphuisen HA. Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 1995; 32: 286 – 91.
41. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001 ; 30: 345 – 54.
42. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009; 360: 1500 – 8.
43. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD. Brown adipose tissue in morbidly obese subjects. PLoS One 2011; 6: e17247.
44. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfi ne AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR. Identifi cation and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360: 1509 – 17.
45. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M. High incidence of meta- bolically active brown adipose tissue in healthy adult humans:
effects of cold exposure and adiposity. Diabetes 2009; 58:
1526 – 31.
46. Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T, Yanagisawa M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 2009; 9: 64 – 76.
Received December 22, 2011; accepted February 21, 2012
Dr. Christopher J. Madden is an Assistant Professor in the Department of Neurological Surgery at Oregon Health and Science University. Dr.
Madden received his PhD in Neuroscience from the University of Pittsburgh in 2002. He was a Postdoctoral Fellow in the laboratory of Dr. Shaun F. Morrison in the Neurological Sciences Institute at Oregon Health and Science University from 2002 to 2008 and then a Staff Scientist at the Oregon National Primate Research Center until obtaining his current position in 2010. Dr. Madden’s research is focused on the functional organization of the central neural circuits regulating metabo- lism of adipose tissue, glucose homeostasis, cardiovascular function, and thermogenesis, and how alterations in this regu- lation contribute to disease states and pathological conditions such as obesity, diabetes, and hypertension. Current tech- niques in use in Dr. Madden’s lab include direct simultaneous recordings of peripheral nerve activities and central nervous system single cell discharge, as well as, pharmacological, functional neuroanatomical, molecular biological, and opto- genetic techniques to investigate the central neural circuits that regulate cardiovascular function, blood glucose homeo- stasis, body temperature, and energy metabolism.
Dr. Domenico Tupone obtained his PhD in Neuro- physiology in 2010 from Alma Mater Studiorum, University of Bologna, Bologna, Italy.
He was honored by the Italian Sleep Research Society (SIRS) with the annual “Igino Fagioli” award for the best doctoral thesis in basic sleep research, for his neurophysi- ological studies on the rela- tionship between REM sleep and central regulation of metabolism. Dr. Tupone is currently a postdoctoral fellow in the laboratory of Prof. Shaun F. Morrison, in the Department of Neurological Surgery at the Oregon Health and Science University, where he studies the central neural regulation of body temperature. Dr. Tupone’s principal research interest is the pharmacological manipulation of the central autonomic circuits controlling body temperature for the development of clinical approaches to controlled hypothermia. His stud- ies implement in vivo, electrophysiological and anatomical approaches in anesthetized, awake head-restrained and free- behaving rats.
Dr. Shaun F. Morrison is a Professor in the Department of Neurological Surgery at Oregon Health and Science University. Dr. Morrison received his PhD in Physio- logy and Biophysics from the University of Vermont. He was an Assistant Professor in the Division of Neurobiology at Cornell University Medical College and subsequently became a Professor in the Department of Physiology at Northwestern University Medical School. Dr. Morrison became a Senior Scientist in the Neurological Sciences Institute at Oregon Health and Science University in 2001, and to his current position in 2010. His research integrates neurophysiological examination of the central thermoregu- latory pathways, from cutaneous thermal afferents to motor outfl ows controlling thermoregulatory effectors, with physi- ological analyses of the interrelationship among thermo- regulatory, cardiovascular, respiratory and metabolic control systems required to maintain the balance of homeostasis.
